vs

Side-by-side financial comparison of OneWater Marine Inc. (ONEW) and Ultragenyx Pharmaceutical Inc. (RARE). Click either name above to swap in a different company.

OneWater Marine Inc. is the larger business by last-quarter revenue ($442.3M vs $207.3M, roughly 2.1× Ultragenyx Pharmaceutical Inc.). OneWater Marine Inc. runs the higher net margin — -2.9% vs -62.0%, a 59.1% gap on every dollar of revenue. On growth, Ultragenyx Pharmaceutical Inc. posted the faster year-over-year revenue change (25.9% vs -8.5%). Over the past eight quarters, Ultragenyx Pharmaceutical Inc.'s revenue compounded faster (38.0% CAGR vs 8.2%).

OneWater Marine Inc. is a leading recreational marine retailer headquartered in the U.S. It sells new and pre-owned boats, yachts and marine parts, offers maintenance, repair and financing services, and serves individual and commercial leisure boating customers across North America through its extensive network of local dealerships.

Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.

ONEW vs RARE — Head-to-Head

Bigger by revenue
ONEW
ONEW
2.1× larger
ONEW
$442.3M
$207.3M
RARE
Growing faster (revenue YoY)
RARE
RARE
+34.4% gap
RARE
25.9%
-8.5%
ONEW
Higher net margin
ONEW
ONEW
59.1% more per $
ONEW
-2.9%
-62.0%
RARE
Faster 2-yr revenue CAGR
RARE
RARE
Annualised
RARE
38.0%
8.2%
ONEW

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ONEW
ONEW
RARE
RARE
Revenue
$442.3M
$207.3M
Net Profit
$-12.9M
$-128.6M
Gross Margin
23.9%
Operating Margin
1.7%
-54.7%
Net Margin
-2.9%
-62.0%
Revenue YoY
-8.5%
25.9%
Net Profit YoY
3.5%
EPS (diluted)
$-0.78
$-1.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ONEW
ONEW
RARE
RARE
Q2 26
$442.3M
Q1 26
$380.6M
Q4 25
$380.6M
$207.3M
Q3 25
$460.1M
$159.9M
Q2 25
$552.9M
$166.5M
Q1 25
$483.5M
$139.3M
Q4 24
$375.8M
$164.6M
Q3 24
$377.9M
$139.5M
Net Profit
ONEW
ONEW
RARE
RARE
Q2 26
$-12.9M
Q1 26
$-7.7M
Q4 25
$-7.7M
$-128.6M
Q3 25
$-113.0M
$-180.4M
Q2 25
$10.7M
$-115.0M
Q1 25
$-368.0K
$-151.1M
Q4 24
$-12.0M
$-133.2M
Q3 24
$-9.2M
$-133.5M
Gross Margin
ONEW
ONEW
RARE
RARE
Q2 26
23.9%
Q1 26
23.5%
Q4 25
23.5%
Q3 25
22.6%
Q2 25
23.3%
Q1 25
22.8%
Q4 24
22.4%
Q3 24
24.0%
Operating Margin
ONEW
ONEW
RARE
RARE
Q2 26
1.7%
Q1 26
Q4 25
-1.4%
-54.7%
Q3 25
-28.3%
-106.9%
Q2 25
5.5%
-64.8%
Q1 25
3.4%
-102.6%
Q4 24
-0.5%
-74.3%
Q3 24
1.2%
-94.6%
Net Margin
ONEW
ONEW
RARE
RARE
Q2 26
-2.9%
Q1 26
-2.0%
Q4 25
-2.0%
-62.0%
Q3 25
-24.5%
-112.8%
Q2 25
1.9%
-69.0%
Q1 25
-0.1%
-108.5%
Q4 24
-3.2%
-80.9%
Q3 24
-2.4%
-95.7%
EPS (diluted)
ONEW
ONEW
RARE
RARE
Q2 26
$-0.78
Q1 26
$-0.47
Q4 25
$-1.28
Q3 25
$-1.81
Q2 25
$-1.17
Q1 25
$-1.57
Q4 24
$-1.34
Q3 24
$-1.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ONEW
ONEW
RARE
RARE
Cash + ST InvestmentsLiquidity on hand
$421.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$269.4M
$-80.0M
Total Assets
$1.4B
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ONEW
ONEW
RARE
RARE
Q2 26
Q1 26
Q4 25
$421.0M
Q3 25
$202.5M
Q2 25
$176.3M
Q1 25
$127.1M
Q4 24
$174.0M
Q3 24
$150.6M
Stockholders' Equity
ONEW
ONEW
RARE
RARE
Q2 26
$269.4M
Q1 26
$277.5M
Q4 25
$277.5M
$-80.0M
Q3 25
$285.0M
$9.2M
Q2 25
$393.2M
$151.3M
Q1 25
$381.6M
$144.2M
Q4 24
$354.8M
$255.0M
Q3 24
$360.8M
$346.8M
Total Assets
ONEW
ONEW
RARE
RARE
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$1.4B
$1.5B
Q3 25
$1.4B
$1.2B
Q2 25
$1.5B
$1.3B
Q1 25
$1.6B
$1.3B
Q4 24
$1.6B
$1.5B
Q3 24
$1.6B
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ONEW
ONEW
RARE
RARE
Operating Cash FlowLast quarter
$-99.8M
Free Cash FlowOCF − Capex
$-100.8M
FCF MarginFCF / Revenue
-48.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-472.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ONEW
ONEW
RARE
RARE
Q2 26
Q1 26
Q4 25
$-76.3M
$-99.8M
Q3 25
$9.9M
$-91.4M
Q2 25
$90.8M
$-108.3M
Q1 25
$28.5M
$-166.5M
Q4 24
$-37.4M
$-79.3M
Q3 24
$27.3M
$-67.0M
Free Cash Flow
ONEW
ONEW
RARE
RARE
Q2 26
Q1 26
Q4 25
$-78.2M
$-100.8M
Q3 25
$7.2M
$-92.7M
Q2 25
$88.9M
$-110.7M
Q1 25
$23.7M
$-167.8M
Q4 24
$-40.0M
$-79.5M
Q3 24
$23.2M
$-68.6M
FCF Margin
ONEW
ONEW
RARE
RARE
Q2 26
Q1 26
Q4 25
-20.6%
-48.6%
Q3 25
1.6%
-58.0%
Q2 25
16.1%
-66.5%
Q1 25
4.9%
-120.5%
Q4 24
-10.7%
-48.3%
Q3 24
6.1%
-49.2%
Capex Intensity
ONEW
ONEW
RARE
RARE
Q2 26
Q1 26
Q4 25
0.5%
0.5%
Q3 25
0.6%
0.8%
Q2 25
0.4%
1.5%
Q1 25
1.0%
1.0%
Q4 24
0.7%
0.1%
Q3 24
1.1%
1.2%
Cash Conversion
ONEW
ONEW
RARE
RARE
Q2 26
Q1 26
Q4 25
Q3 25
Q2 25
8.47×
Q1 25
Q4 24
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ONEW
ONEW

New boat$272.0M62%
Pre-owned boat$94.4M21%
Service, parts & other$61.9M14%
Finance & insurance income$14.0M3%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

Related Comparisons